<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 06:20:59 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>How To Profit From The 'Next' Dubai</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</guid>
      <description><![CDATA[The Dubai World default is a matter of only $60 billion – mere peanuts when compared to other elements of the global financial crisis. It’s thus of concern only to those silly enough to invest in real estate there (and the European banks foolish enough to finance it.) For the rest of us, it is a useful reminder that sudden collapses don’t really come out of nowhere – they can be foreseen, and smart investors can plan for them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3679796>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 13:51:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</link>
    </item>
    <item>
      <title>Personalized Anti-Cancer Vaccine, BiovaxID®, Targeting B-cell Lymphomas Available in Europe on a Named-Patient Basis</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3317923</guid>
      <description><![CDATA[Biovest International, Inc. (Other OTC:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC:ABPIQ), today announced that BiovaxID&#174;, Biovest’s personalized therapeutic anti-cancer vaccine, is available on a named-patient (compassionate-use) basis in Europe. Following compliance with local regulatory protocols, BiovaxID will be supplied by idis Limited to European healthcare professionals for the treatment of follicular non-Hodgkin’s lymphoma and potentially for other B-cell blood cancers such as chronic lymphocytic leukemia, mantle cell lymphoma and multiple myeloma. Physicians in non-European countries may also contact idis to inquire about the potential availability of BiovaxID, as idis manages named-patient programs in more than 100 countries.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3317923>[More...]</a>]]></description>
      <pubDate>Sun, 28 Jun 2009 11:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPIQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3317923</link>
    </item>
    <item>
      <title>Biovest International Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize its Drugs and Technologies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2783381</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (Other OTC:ABPI), today announced that, primarily due to the disruption in the U.S. capital and finance markets which limited access to required funding, the Company has filed a voluntary petition for reorganization. With existing cash flow and the potential for relatively near-term significant business development opportunities for BiovaxID&#174; and AutovaxID™, this action is intended to provide an opportunity for the Company to restore shareholder value and to pay all secured and unsecured creditors. Under protection of the court, Biovest plans to implement a series of initiatives designed to significantly decrease operating expenses and financing costs, and focus cash and resources on its priority programs that will allow the Company to attract key funding/partnering opportunities. Affiliates of the Company, including Hopkins Capital Group, LLC, a major shareholder, have indicated a willingness to provide additional financing to the Company as part of its reorganization plan. A conference call and webcast is scheduled for 4:30 p.m. (EST) this afternoon to further discuss this action.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2783381>[More...]</a>]]></description>
      <pubDate>Mon, 10 Nov 2008 15:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2783381</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals Announces Reorganization Plan to Maximize Long-Term Shareholder Value, Fully Pay All Creditors and Continue Operations to Commercialize Its Drug Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2783614</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (Pink Sheets:ABPI) today announced that the Company and its subsidiaries have filed voluntary petitions for reorganization. With existing cash flows from subsidiaries and the potential for relatively near-term significant business development opportunities, this action is intended to provide an opportunity for the Company to restore shareholder value and to pay secured and unsecured creditors. Under protection of the court, Accentia plans to implement a series of initiatives designed to significantly decrease operating expenses and financing costs, and focus cash and resources on drug development and other priority programs that will allow the Company to attract key funding/partnering opportunities. Affiliates of the Company, including Hopkins Capital Group, LLC, a major shareholder, have indicated a willingness to provide additional financing to the Company as part of its reorganization plan. A conference call and webcast is scheduled for 4:30 p.m. (EST) this afternoon to further discuss this action.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2783614>[More...]</a>]]></description>
      <pubDate>Mon, 10 Nov 2008 15:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2783614</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals Announces Pending Delisting from NASDAQ</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2762975</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) today announced that the Company elected not to appeal the NASDAQ Stock Market’s Staff determination to delist Accentia’s shares of common stock from the NASDAQ Capital Market. As previously reported, Accentia received notice from the NASDAQ Stock Market dated October 24, 2008, notifying the Company that it is not in compliance with Rule 4310(c)(3)(B), requiring a minimum $35 million market value. As a result, at the opening of business on November 4, 2008, shares of Accentia will open for trading listed on the Pink Sheets, an electronic quotation service for securities traded over-the-counter. Accentia’s stock ticker symbol will remain the same (“ABPI”).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2762975>[More...]</a>]]></description>
      <pubDate>Mon, 03 Nov 2008 20:19:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2762975</link>
    </item>
    <item>
      <title>Biovest and IDIS Announce Agreement to Launch Named-Patient Program for Anti-Cancer Vaccine in Europe</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2747992</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI), today announced that it has executed a distribution agreement with IDIS Limited to exclusively supply BiovaxID&#174; (personalized, anti-idiotype cancer vaccine) under a Named-Patient Program in France, Germany, Italy, Greece, Spain and the United Kingdom. IDIS is a leading European drug distributor, and under terms of this agreement, sales of BiovaxID are expected to commence in the first calendar quarter of 2009, with the anti-cancer vaccine being made available to those patients suffering from various B-cell related blood cancers including: chronic lymphocytic leukemia; mantle cell lymphoma; multiple myeloma; and non-Hodgkin’s lymphoma.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2747992>[More...]</a>]]></description>
      <pubDate>Wed, 29 Oct 2008 13:27:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2747992</link>
    </item>
    <item>
      <title>Accentia Biopharmaceuticals to Present at Rodman &amp; Renshaw 10th Annual Healthcare Conference; Company Also Reports On NASDAQ Compliance Plan</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2737290</guid>
      <description><![CDATA[Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that it will present at the Rodman &amp; Renshaw 10th Annual Healthcare Conference on November 11, 2008 at 10:20 a.m. (EDT) at the New York Palace Hotel in New York City. The Company’s presentation will focus on its BiovaxID&#174; personalized anti-cancer vaccine. Accentia’s majority-owned subsidiary, Biovest International, Inc. (OTCBB:BVTI), recently reported encouraging BiovaxID Phase 3 clinical trial results for the treatment of non-Hodgkin’s lymphoma, and the Company is now progressing with plans to seek approvals in the U.S., Europe and other international countries.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2737290>[More...]</a>]]></description>
      <pubDate>Fri, 24 Oct 2008 21:11:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2737290</link>
    </item>
    <item>
      <title>Biovest Announces $1.6M in Federal Funding Appropriated for Groundbreaking Cancer Vaccine &amp; Skin/Bone/Tissue Repair Research</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2729980</guid>
      <description><![CDATA[Biovest International, Inc. (OTCBB:BVTI) today announced that the U.S. Federal Government has approved the appropriation of $1.6 million in biomedical research funds for Fiscal Year 2009 for the Defense Department's Cancer Immunotherapy and Cell Therapy Initiative, which is intended to support research into new applications for the AutovaxID™ instrument, Biovest's fully-automated cell-manufacturing device to cost-effectively and efficiently manufacture difficult-to-produce therapeutic proteins and personalized vaccines, including vaccines targeting cancers.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2729980>[More...]</a>]]></description>
      <pubDate>Wed, 22 Oct 2008 18:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2729980</link>
    </item>
    <item>
      <title>Form  4          OSMAN RONALD E            For: May 22 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3245005</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3245005>[More...]</a>]]></description>
      <pubDate>Tue, 26 May 2009 22:41:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3245005</link>
    </item>
    <item>
      <title>Form  4          BIOVEST INTERNATIONAL     For: Oct 06  Filed by: OSMAN RONALD E (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2684323</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2684323>[More...]</a>]]></description>
      <pubDate>Mon, 06 Oct 2008 22:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2684323</link>
    </item>
    <item>
      <title>Form  4          BIOVEST INTERNATIONAL     For: Sep 26  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2665222</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2665222>[More...]</a>]]></description>
      <pubDate>Tue, 30 Sep 2008 22:25:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2665222</link>
    </item>
    <item>
      <title>Form  4          OSMAN RONALD E            For: Sep 18 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2629094</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2629094>[More...]</a>]]></description>
      <pubDate>Thu, 18 Sep 2008 15:21:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BVTI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2629094</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 11  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2508735</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2508735>[More...]</a>]]></description>
      <pubDate>Wed, 13 Aug 2008 13:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2508735</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 08  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2498513</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2498513>[More...]</a>]]></description>
      <pubDate>Mon, 11 Aug 2008 12:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2498513</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 06  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2487702</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2487702>[More...]</a>]]></description>
      <pubDate>Thu, 07 Aug 2008 12:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2487702</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 05  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2481776</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2481776>[More...]</a>]]></description>
      <pubDate>Wed, 06 Aug 2008 12:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2481776</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Aug 04  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2476366</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2476366>[More...]</a>]]></description>
      <pubDate>Tue, 05 Aug 2008 14:23:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2476366</link>
    </item>
    <item>
      <title>Form  4          ACCENTIA BIOPHARMACEUTIC  For: Jul 31  Filed by: ODONNELL FRANCIS E JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/2464843</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/2464843>[More...]</a>]]></description>
      <pubDate>Fri, 01 Aug 2008 19:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/2464843</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ABPI,BVTI," rel="self" type="application/rss+xml" />
  </channel>
</rss>